S-metoprolol/telmisartan

Drug Profile

S-metoprolol/telmisartan

Alternative Names: FDC metoprolol/telmasartan; Metpure-Tel 20; Metpure-Tel 40; S-metoprolol - Emcure; Telmasartan/S-metoprolol; Telmisartan - Emcure

Latest Information Update: 12 Jan 2012

Price : $50

At a glance

  • Originator Emcure Pharmaceuticals
  • Class Antihypertensives; Benzimidazoles; Benzoates; Small molecules
  • Mechanism of Action ACE inhibitors; Angiotensin type 1 receptor antagonists; Beta-adrenergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Essential hypertension

Most Recent Events

  • 31 Dec 2011 Launched for Essential hypertension (met-25mg/tel-40mg) in India (PO)
  • 31 Dec 2011 Launched for Essential hypertension (met-25mg/tel-20mg) in India (PO)
  • 30 Jun 2011 Phase-III clinical trials in Essential hypertension (met-25mg/tel-40mg) in India (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top